يعرض 1 - 10 نتائج من 24 نتيجة بحث عن '"Àcids biliars"', وقت الاستعلام: 1.01s تنقيح النتائج
  1. 1
    رسالة جامعية
  2. 2
    رسالة جامعية

    المؤلفون: Pedraz Cuesta, Elena

    المساهمون: University/Department: Universitat de Barcelona. Departament de Bioquímica i Biologia Molecular (Farmàcia)

    مرشدي الرسالة: Rodríguez Rubio, Joan Carles

    المصدر: TDX (Tesis Doctorals en Xarxa)

    وصف الملف: application/pdf

    الوصول الحر: http://hdl.handle.net/10803/96130Test

  3. 3
    دورية أكاديمية

    المساهمون: Institut Català de la Salut, Hansen BE Department of Hepatology, Toronto General Hospital University Health Network, Toronto, Ontario, Canada. Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada. Department of Epidemiology, Erasmus MC, Rotterdam, The Netherlands. Vandriel SM Department of Paediatrics, Division of Gastroenterology, Hepatology and Nutrition, The Hospital for Sick Children and the University of Toronto, Toronto, Ontario, Canada. Vig P, Garner W, Mogul DB Department of Scientific and Medical Affairs, Mirum Pharmaceuticals, Inc., Foster City, California, USA. Loomes KM Department of Pathology and Laboratory Medicine, Division of Gastroenterology, Hepatology and Nutrition, The Children’s Hospital of Philadelphia and the University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA. Quintero J Unitat de Gastroenterologia, Hepatologia, Suport Nutricional i Trasplantaments Hepàtics Pediàtrics, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Department of Liver and Gastrointestinal Diseases, Biodonostia Health Research Institute—Donostia University Hospital, University of the Basque Country (UPV/EHU), San Sebastian, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    العلاقة: Hepatology;79(6); https://doi.org/10.1097/HEP.0000000000000727Test; Hansen BE, Vandriel SM, Vig P, Garner W, Mogul DB, Loomes KM, et al. Event-free survival of maralixibat-treated patients with Alagille syndrome compared to a real-world cohort from GALA. Hepatology. 2024 Jun 1;79(6):1279–92.; https://hdl.handle.net/11351/11490Test; 001180943000001

  4. 4
    دورية أكاديمية

    المساهمون: Institut Català de la Salut, Felzen A, van Wessel DBE Pediatric Gastroenterology and Hepatology, University Medical Center Groningen, University of Groningen, the Netherlands. Gonzales E Pediatric Hepatology & Pediatric Liver Transplant Department, Centre de Référence de l'Atrésie des Voies Biliaires et des Cholestases Génétiques, Filière de Santé des Maladies Rares du Foie de l'enfant et de l'adulte, Assistance Publique-Hôpitaux de Paris, Faculté de Médecine Paris-Saclay, CHU Bicêtre, Paris, France. European Reference Network on Hepatological Diseases (ERN RARE-LIVER). INSERM, Hepatinov, Université Paris-Saclay, Orsay, France. Thompson RJ Institute of Liver Studies, King's College London, London, United Kingdom. Jankowska I European Reference Network on Hepatological Diseases (ERN RARE-LIVER). Gastroenterology, Hepatology, Nutritional Disorders and Pediatrics, The Children’s Memorial Health Institute, Warsaw, Poland. Shneider BL Division of Pediatric Gastroenterology, Hepatology, and Nutrition, Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA. Childhood Liver Disease Research Network (ChiLDReN). Quintero Bernabeu J European Reference Network on Hepatological Diseases (ERN RARE-LIVER). Unitat de Gastroenterologia, Hepatologia, Suport Nutricional i Trasplantaments Hepàtics Pediàtrics, Vall d'Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    العلاقة: JHEP Reports;5(2); https://doi.org/10.1016/j.jhepr.2022.100626Test; Felzen A, van Wessel DBE, Gonzales E, Thompson RJ, Jankowska I, Shneider BL, et al. Genotype-phenotype relationships of truncating mutations, p.E297G and p.D482G in bile salt export pump deficiency. JHEP Rep. 2023 Feb;5(2):100626.; https://hdl.handle.net/11351/9086Test

  5. 5
    دورية أكاديمية

    المساهمون: Institut Català de la Salut, Alonso-Peña M Experimental Hepatology and Drug Targeting (HEVEPHARM), Institute for Biomedical Research of Salamanca (IBSAL), University of Salamanca, Salamanca, Spain. Gastroenterology and Hepatology Department, Clinical and Translational Research in Digestive Diseases, Valdecilla Research Institute (IDIVAL), Marqués de Valdecilla University Hospital, Santander, Spain. Division of Hepatology, Würzburg University Hospital, Medical Clinic II, Würzburg, Germany. Espinosa-Escudero R Experimental Hepatology and Drug Targeting (HEVEPHARM), Institute for Biomedical Research of Salamanca (IBSAL), University of Salamanca, Salamanca, Spain. Hermanns HM Division of Hepatology, Würzburg University Hospital, Medical Clinic II, Würzburg, Germany. Briz O Experimental Hepatology and Drug Targeting (HEVEPHARM), Institute for Biomedical Research of Salamanca (IBSAL), University of Salamanca, Salamanca, Spain. Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Carlos III National Institute of Health, Madrid, Spain. Herranz JM Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Carlos III National Institute of Health, Madrid, Spain. Hepatology Program, Liver Unit, Instituto de Investigación de Navarra (IdisNA), Clínica Universidad de Navarra and Centro de Investigación Médica Aplicada (CIMA), Universidad de Navarra, Pamplona, Spain. Garcia-Ruiz C Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Carlos III National Institute of Health, Madrid, Spain. Institute of Biomedical Research of Barcelona (IIBB), Centro Superior de Investigaciones Científicas (CSIC), Barcelona, Spain. Center for ALPD, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA. Juamperez J Unitat de Gastroenterologia, Hepatologia, Suport Nutricional i Trasplantaments Hepàtics Pediàtrics, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    العلاقة: Cells;11(24); https://doi.org/10.3390/cells11243983Test; Alonso-Peña M, Espinosa-Escudero R, Hermanns HM, Briz O, Herranz JM, Garcia-Ruiz C, et al. Impact of Liver Inflammation on Bile Acid Side Chain Shortening and Amidation. Cells. 2022 Dec 9;11(24):3983.; https://hdl.handle.net/11351/8872Test

  6. 6
    دورية أكاديمية
  7. 7
    دورية أكاديمية
  8. 8

    المساهمون: Institut Català de la Salut, [Alonso-Peña M] Experimental Hepatology and Drug Targeting (HEVEPHARM), Institute for Biomedical Research of Salamanca (IBSAL), University of Salamanca, Salamanca, Spain. Gastroenterology and Hepatology Department, Clinical and Translational Research in Digestive Diseases, Valdecilla Research Institute (IDIVAL), Marqués de Valdecilla University Hospital, Santander, Spain. Division of Hepatology, Würzburg University Hospital, Medical Clinic II, Würzburg, Germany. [Espinosa-Escudero R] Experimental Hepatology and Drug Targeting (HEVEPHARM), Institute for Biomedical Research of Salamanca (IBSAL), University of Salamanca, Salamanca, Spain. [Hermanns HM] Division of Hepatology, Würzburg University Hospital, Medical Clinic II, Würzburg, Germany. [Briz O] Experimental Hepatology and Drug Targeting (HEVEPHARM), Institute for Biomedical Research of Salamanca (IBSAL), University of Salamanca, Salamanca, Spain. Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Carlos III National Institute of Health, Madrid, Spain. [Herranz JM] Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Carlos III National Institute of Health, Madrid, Spain. Hepatology Program, Liver Unit, Instituto de Investigación de Navarra (IdisNA), Clínica Universidad de Navarra and Centro de Investigación Médica Aplicada (CIMA), Universidad de Navarra, Pamplona, Spain. [Garcia-Ruiz C] Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Carlos III National Institute of Health, Madrid, Spain. Institute of Biomedical Research of Barcelona (IIBB), Centro Superior de Investigaciones Científicas (CSIC), Barcelona, Spain. Center for ALPD, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA. [Juamperez J] Unitat de Gastroenterologia, Hepatologia, Suport Nutricional i Trasplantaments Hepàtics Pediàtrics, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain, Vall d'Hebron Barcelona Hospital Campus, Centro de Investigación Biomédica en Red Enfermedades Hepáticas y Digestivas (España), Instituto de Salud Carlos III, European Commission, Junta de Castilla y León, Fundació La Marató de TV3, Asociación Española Contra el Cáncer, Interdisciplinary Center for Clinical Research (Germany), Agencia Estatal de Investigación (España), Ministerio de Ciencia, Innovación y Universidades (España), Generalitat de Catalunya, European Cooperation in Science and Technology, Fundación Echebano

    المصدر: Scientia
    Cells; Volume 11; Issue 24; Pages: 3983

    وصف الملف: application/pdf

  9. 9
    رسالة جامعية
  10. 10
    دورية أكاديمية